Invictus RG’s Cantel Medical Corporation CMD Stock Holding History

Invictus RG’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,976	Closed	-$469K	–	561
2017 Q3	$469K	Buy	+4,976	New	+$393K	0.42%	65

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Invictus RG's CMD Position: Q4 2017 in Review

Invictus RG sold out of Cantel Medical Corporation (CMD) in Q4 2017, closing a stake of 4,976 shares — an estimated $469K sold.

Invictus RG first reported a position in CMD in Q3 2017 and held it in 1 quarter. The position peaked at $469K in Q3 2017. 245 funds tracked by Wall St. Rank hold CMD as of Q4 2017.

Invictus RG reported no remaining Cantel Medical Corporation position as of Q4 2017 after selling out during the quarter.
Invictus RG sold 4,976 Cantel Medical Corporation shares in Q4 2017, an estimated $469K.
Invictus RG first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 1 quarter.
Invictus RG's Cantel Medical Corporation position peaked at $469K in Q3 2017.
245 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2017.

Based on Invictus RG's 13F filing for Q4 2017, filed 13 Feb 2018.